This trial has been completed.

Condition heart failure
Sponsor Massachusetts General Hospital
Start date March 2012
End date October 2015
Trial size 30 participants
Trial identifier NCT01568619, AESCULON


The investigators would like to find out if AESCULON®, a new device that non-invasively and continuously measures cardiac output using electrical cardiometry, works as well as one existing method--Fick method in patients undergoing cardiopulmonary exercise testing.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

difference in CO measurements with two methods
time frame: two weeks after finishing the exercise test

Eligibility Criteria

All participants at least 18 years old.

Inclusion Criteria: - Age >= 18 yd; - Level 3 cardiopulmonary exercise testing. Exclusion Criteria: - Proven or suspected disease involving severe aortic regurgitation; - Implanted with a rate-responsive cardiac pacemaker; - Pneumothorax or pleural effusion; - Skin lesion(s) at the place where the electrode is supposed to be applied; - Allergic to adhesive of ECG electrodes.

Additional Information

Official title Validation of Electrical Cardiometry Versus Fick Method to Measure Stroke Volume and Cardiac Output in Patients With or Suspected of Having Heart Failure
Principal investigator Yandong Jiang, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Massachusetts General Hospital.